News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

TRANSGENE (ENX:TNG) Reports Fiscal Year 2013 Results And Provides Business Update


3/27/2014 6:58:03 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Regulatory News:

Highlights from the consolidated financial results for 2013 included a stable net loss of €42.9 million compared to €43.2 million in 2012 and net cash burn of €45.0 million (€46.6 million in 2012). As of December 31, 2013, the Company had €47.9 million in cash, cash equivalents and other financial assets.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES